Abstract
The treatment of a particular patient’s coronary artery disease (CAD) will depend on the severity of the symptoms and the patient’s pathological condition. In addition to pain, patients may suffer from other symptoms, such as severe fatigue, dyspnea, abdominal pain, nausea and sweating. And in order to understand cardiac pain, one requires knowledge of the interplay between ischemic, metabolic and neurological mechanisms behind CAD. This chapter presents the alternative therapies for stable ischemic heart disease (SIHD) and for acute coronary syndrome (ACS), such as drug therapy, invasive therapy and minimally invasive therapy. Reference is made to the National Institute for Health and Care Excellence (NICE) 2011 respective guidelines, which recommend medical therapy for chronic stable angina and reperfusion therapy for patients with STEMI.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bonow RO, Mann DL, Zipes DP, Libby P. Braunwald’s heart disease: a textbook of cardiovascular medicine. Philadelphia: Elsevier/Saunders; 2015.
Kyavar M, Alemzadeh-Ansari M. Chapter 35 – Stable ischemic heart disease. In: Maleki M, Alizadehasl A, Haghjoo M, editors. Practical cardiology. St. Louis: Elsevier; 2018. p. 591–630.
Sedehi D, Cigarroa JE. Chapter 6 – Precipitants of myocardial ischemia. In: de Lemos JA, Omland T, editors. Chronic coronary artery disease. Philadelphia: Elsevier; 2018. p. 69–77.
Amsterdam EA, Wenger NK, Brindis RG, Casey J, Donald E, Ganiats TG, Holmes J, David R, et al. 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;64(24):e139.
Kwon L, Rosendorff C. Chapter 20 – The medical treatment of stable angina. In: de Lemos JA, Omland T, editors. Chronic coronary artery disease. Philadelphia: Elsevier; 2018. p. 280–302.
Tang J, Shen D, Caranasos TG, Wang Z, Vandergriff AC, Allen TA, et al. Therapeutic microparticles functionalized with biomimetic cardiac stem cell membranes and secretome. Nat Commun. 2017;8:13724.
Yang J, Zeng Y, Zhang C, Chen Y, Yang Z, Li Y, et al. The prevention of restenosis in vivo with a VEGF gene and paclitaxel co-eluting stent. Biomaterials. 2013;34(6):1635–43.
Fihn SD, Gardin JM, Abrams J, Berra K, Blankenship JC, Dallas AP, et al. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2012;60(24):e44–e164.
Firouzi A. Chapter 20 – Percutaneous coronary intervention. In: Maleki M, Alizadehasl A, Haghjoo M, editors. Practical cardiology. St. Louis: Elsevier; 2018. p. 329–35.
Michos ED, Blaha MJ, Martin SS, Blumenthal RS. Chapter 29 – Screening for atherosclerotic cardiovascular disease in asymptomatic individuals. In: de Lemos JA, Omland T, editors. Chronic coronary artery disease. Philadelphia: Elsevier; 2018. p. 459–78.
Watson KE, Guo Y, Sahni S. Chapter 30 – Secondary prevention of coronary artery disease. In: de Lemos JA, Omland T, editors. Chronic coronary artery disease. Philadelphia: Elsevier; 2018. p. 479–87.
O’Gara PT, Kushner FG, Ascheim DD, Casey J, Donald E, Chung MK, de Lemos JA, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol. 2013;61(4):e78.
Ducrocq G, Steg PG. Chapter 21 – Antiplatelet and anticoagulant drugs. In: de Lemos JA, Omland T, editors. Chronic coronary artery disease. Philadelphia: Elsevier; 2018. p. 303–20.
Capodanno D, Angiolillo DJ. Antiplatelet therapy after implantation of bioresorbable vascular scaffolds. J Am Coll Cardiol Intv. 2017;10(5):425.
Marso SP. Chapter 23 – Revascularization approaches. In: de Lemos JA, Omland T, editors. Chronic coronary artery disease. Philadelphia: Elsevier; 2018. p. 337–54.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2020 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
King, M.W., Bambharoliya, T., Ramakrishna, H., Zhang, F. (2020). Treatment of Coronary Artery Disease (CAD). In: Coronary Artery Disease and The Evolution of Angioplasty Devices. SpringerBriefs in Materials. Springer, Cham. https://doi.org/10.1007/978-3-030-42443-5_5
Download citation
DOI: https://doi.org/10.1007/978-3-030-42443-5_5
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-42442-8
Online ISBN: 978-3-030-42443-5
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)